Infection risk in patients on multiple sclerosis therapeutics.
about
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerationsProgressive Multifocal LeukoencephalopathyCritical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.Vaccines in Multiple Sclerosis.Vaccines and multiple sclerosis: a systematic review.Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.Circulating lymphocyte levels and relationship with infection status in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta.The transition from first-line to second-line therapy in multiple sclerosis.Infections in patients with multiple sclerosis: Implications for disease-modifying therapy.Infections and the relationship to treatment in neuromuscular autoimmunity.Vaccines and multiple sclerosis.
P2860
Q26752859-D1A850C2-AF25-4A5F-A63E-B52326B6D75EQ26766172-8AD2D70D-9F3C-4EC8-A019-7B99F2787A2EQ36951404-2440CCBC-913D-44C2-9191-B754DAB88267Q38591114-8BD038F4-7587-4CE3-9AEF-13DFFFD48F9EQ38752982-C27D43AE-12CF-40EF-89AF-15F71E036735Q38948785-9889C6CF-25C7-4CC7-A681-3CDD172E054CQ40039520-2616F4F1-6EDB-46E5-976D-325FA530A47AQ40044090-DC8421EF-8E85-4A00-9692-5C38BC66AA59Q41014662-C1DBE2A3-1D54-4488-98C2-8B554F1710A5Q47600984-B8CAA39F-C773-4294-903D-E7C2E86B869BQ48166707-BED14E7F-AC19-4DC1-B882-AF45A9258208Q50080890-53F5FAB1-D8B8-4A91-B81A-273965C3AC16
P2860
Infection risk in patients on multiple sclerosis therapeutics.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Infection risk in patients on multiple sclerosis therapeutics.
@ast
Infection risk in patients on multiple sclerosis therapeutics.
@en
type
label
Infection risk in patients on multiple sclerosis therapeutics.
@ast
Infection risk in patients on multiple sclerosis therapeutics.
@en
prefLabel
Infection risk in patients on multiple sclerosis therapeutics.
@ast
Infection risk in patients on multiple sclerosis therapeutics.
@en
P2860
P1433
P1476
Infection risk in patients on multiple sclerosis therapeutics.
@en
P2093
Eric M Williamson
Joseph R Berger
P2860
P2888
P304
P356
10.1007/S40263-015-0226-2
P577
2015-03-01T00:00:00Z